1IMS
MOLECULAR STRUCTURE OF THE HALOGENATED ANTI-CANCER DRUG IODODOXORUBICIN COMPLEXED WITH D(TGTACA) AND D(CGATCG)
Functional Information from PDB Data
| site_id | 1 |
| Number of Residues | |
| Details |
| Chain | Residue |
| site_id | AC1 |
| Number of Residues | 14 |
| Details | BINDING SITE FOR RESIDUE DM7 A 7 |
| Chain | Residue |
| A | DC1 |
| A | HOH25 |
| A | HOH35 |
| A | HOH37 |
| A | HOH41 |
| A | HOH43 |
| A | DG2 |
| A | DA3 |
| A | DT4 |
| A | DC5 |
| A | DG6 |
| A | HOH10 |
| A | HOH14 |
| A | HOH17 |
